NCT02450682View on ClinicalTrials.gov

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

March 31, 2017

Conditions
Atrial Fibrillation
Interventions
DRUG

Apixaban

Anticoagulant agent for Atrial Fibrillation and undergo CIED generator change

DRUG

Warfarin

Anticoagulant agent for Atrial Fibrillation and undergo CIED generator change

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Mayo Clinic

OTHER